Beryl Drugs (BOM:524606) Price-to-Operating-Cash-Flow : (As of Jun. 04, 2025)

View and export this data going back to 1994. Start your Free Trial

What is Beryl Drugs Price-to-Operating-Cash-Flow?

As of today (2025-06-04), Beryl Drugs's share price is ₹19.29. Beryl Drugs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.00. Hence, Beryl Drugs's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Beryl Drugs's Price-to-Operating-Cash-Flow or its related term are showing as below:

BOM:524606' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 0 Max: 11.4
Current: 11.4

During the past 13 years, Beryl Drugs's highest Price-to-Operating-Cash-Flow Ratio was 11.40. The lowest was 0.00. And the median was 0.00.

BOM:524606's Price-to-Operating-Cash-Flow is ranked better than
67.1% of 687 companies
in the Drug Manufacturers industry
Industry Median: 17.54 vs BOM:524606: 11.40

Beryl Drugs's Cash Flow from Operations per share for the three months ended in Dec. 2024 was ₹0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 34.30% per year.

During the past 13 years, Beryl Drugs's highest 3-Year average Operating Cash Flow per Share Growth Rate was 134.80% per year. The lowest was -21.80% per year. And the median was 26.20% per year.

Beryl Drugs Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Beryl Drugs's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beryl Drugs Price-to-Operating-Cash-Flow Chart

Beryl Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

10.03

9.91

2.58

18.14

Beryl Drugs Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	18.14	-	-	-

Competitive Comparison of Beryl Drugs's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Beryl Drugs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beryl Drugs's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beryl Drugs's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Beryl Drugs's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Beryl Drugs Price-to-Operating-Cash-Flow Calculation

Beryl Drugs's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	19.29	/	0
	=

Beryl Drugs's Share Price of today is ₹19.29.
Beryl Drugs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Beryl Drugs Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Beryl Drugs's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Beryl Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beryl Drugs Ltd (BOM:524606) » Definitions » Price-to-Operating-Cash-Flow

Traded in Other Exchanges

N/A

Address

133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001

Website

https://www.beryldrugs.com

Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.

Beryl Drugs Headlines

No Headlines